Product NDC: | 50268-629 |
Proprietary Name: | Oxybutynin Chloride |
Non Proprietary Name: | Oxybutynin Chloride |
Active Ingredient(s): | 15 mg/1 & nbsp; Oxybutynin Chloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50268-629 |
Labeler Name: | AvPAK |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078503 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120516 |
Package NDC: | 50268-629-13 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (50268-629-13) |
NDC Code | 50268-629-13 |
Proprietary Name | Oxybutynin Chloride |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (50268-629-13) |
Product NDC | 50268-629 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxybutynin Chloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120516 |
Marketing Category Name | ANDA |
Labeler Name | AvPAK |
Substance Name | OXYBUTYNIN CHLORIDE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |